| Literature DB >> 30996938 |
Bo Jin1, Fabrice Gallou2, John Reilly3, Bruce H Lipshutz1.
Abstract
A new catalyst that derives from commercially available precursors for copper-free, Pd-catalyzed Sonogashira reactions at the sustainable ppm level of precious metal palladium under mild aqueous micellar conditions has been developed. Both the palladium pre-catalyst and ligand are commercially available, bench stable, and highly cost-effective. The catalyst is applicable to both aryl- and heteroaryl-bromides as educts. A wide range of functional groups are tolerated and the aqueous reaction medium can be recycled. An application to a key intermediate associated with an active pharmaceutical ingredient (ponatinib) is discussed.Entities:
Year: 2019 PMID: 30996938 PMCID: PMC6438147 DOI: 10.1039/c8sc05618h
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1Structures of cBRIDP ligand, pre-catalyst [Pd(cinnamyl)Cl]2 and in situ-derived catalyst 1 used in this model reaction.
Representative Sonogashira couplings in water catalyzed by (A) 1000 or (B) 1500 ppm Pd ,
|
|
|
|
Conditions: bromide (0.5 mmol), [(cinnamyl)PdCl]2 (0.05 mol%), cBRIDP (0.30 mol%), terminal alkyne (0.60 mmol), K3PO4·H2O (2.0 equiv.), TPGS-750-M/H2O (2 wt%, 1 mL), 45 °C, Ar.
Isolated yield.
Et3N (2.0 equiv.) as base.
Reaction run at 35 °C, 1.1 equiv. of terminal alkyne used.
1.5 equiv. of terminal alkyne used.
Scheme 22-Step, 1-pot process using an initial 1000 ppm Pd-catalyzed Sonogashira coupling in water.
Scheme 3ICP-MS analyses of residual palladium in products 4 and 11.
Scheme 4Recycling study and E factor determination.
Scheme 5Synthesis of ponatinib. Conditions: step: (A) 24 (1.0 equiv.), (triethylsilyl)acetylene (2.0 equiv.), [(cinnamyl)PdCl]2 (0.075 mol%), cBRIDP (0.45 mol%), Et3N (2.0 equiv.), 0.5 M in 2 wt% TPGS-750-M/H2O, 45 °C, Ar, 45 h; step: (B) 25 (1.0 equiv.), K2CO3 (20 mol%), 0.5 M in 1 : 1 MeOH/THF, 45 °C, 5 h; step (C): imidazo[1,2-b]pyridazine (1.0 equiv.), N-iodosuccinimide (1.2 equiv.), 0.53 M in DMF, 80 °C, Ar, overnight; step (D): 27 (1.0 equiv.), 26 (1.2 equiv.), [(cinnamyl)PdCl]2 (0.075 mol%), cBRIDP (0.45 mol%), Et3N (2.0 equiv.), 0.5 M in 2 wt% TPGS-750-M/H2O, 45 °C, Ar, 47 h. Step (E): 28 (1.0 equiv.), 4-(4-methyl-piperazinomethyl)-3-(trifluoromethyl)aniline (1.0 equiv.), KO-t-Bu (2.0 equiv.), 0.17 M in THF, rt, Ar, 12 h.